1.
J Eur Acad Dermatol Venereol
; 30(2): 355-6, 2016 Feb.
Article
in English
| MEDLINE
| ID: mdl-25327640
Subject(s)
Biological Therapy/adverse effects , Immunoglobulins, Intravenous/adverse effects , Multiple Sclerosis/drug therapy , Psoriasis/complications , Skin/pathology , Adult , Humans , Immunoglobulins, Intravenous/administration & dosage , Immunologic Factors/administration & dosage , Immunologic Factors/adverse effects , Male , Multiple Sclerosis/complications , Psoriasis/pathology , Recurrence , Severity of Illness Index
2.
J Eur Acad Dermatol Venereol
; 30(4): 713-5, 2016 Apr.
Article
in English
| MEDLINE
| ID: mdl-25683124
3.
Clin Exp Dermatol
; 37(6): 639-41, 2012 Aug.
Article
in English
| MEDLINE
| ID: mdl-22300412
ABSTRACT
Pityriasis amiantacea (PA; also known as tinea amiantacea) is a relatively rare but distinctive scalp condition characterized by thick scales that adhere to each other and to the hair shaft, resulting in agglomeration and matting of hair. Temporary alopecia is a common complication. Although a specific cause remains unclear, PA is associated with several inflammatory diseases such as psoriasis and seborrhoeic dermatitis. We present a case of PA as a complication of underlying psoriasis, which developed during tumour necrosis factor (TNF)-α inhibitor therapy for Crohn disease. This paradoxical cutaneous reaction to anti-TNF-α therapy has been recently described as an emerging and perplexing cause of psoriasis and psoriasiform eruptions.